<?xml version='1.0' encoding='utf-8'?>
<document id="25677697"><sentence text="Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma."><entity charOffset="40-52" id="DDI-PubMed.25677697.s1.e0" text="pralatrexate" /><entity charOffset="57-67" id="DDI-PubMed.25677697.s1.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.25677697.s1.e0" e2="DDI-PubMed.25677697.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25677697.s1.e0" e2="DDI-PubMed.25677697.s1.e1" /></sentence><sentence text="T-cell lymphomas (TCL) are aggressive diseases, which carry a poor prognosis" /><sentence text=" The emergence of new drugs for TCL has created a need to survey these agents in a rapid and reproducible fashion, to prioritize combinations which should be prioritized for clinical study" /><sentence text=" Mouse models of TCL that can be used for screening novel agents and their combinations are lacking" /><sentence text=" Developments in noninvasive imaging modalities, such as surface bioluminescence (SBL) and three-dimensional ultrasound (3D-US), are challenging conventional approaches in xenograft modeling relying on caliper measurements" /><sentence text=" The recent approval of pralatrexate and romidepsin creates an obvious combination that could produce meaningful activity in TCL, which is yet to be studied in combination"><entity charOffset="24-36" id="DDI-PubMed.25677697.s6.e0" text="pralatrexate" /><entity charOffset="41-51" id="DDI-PubMed.25677697.s6.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.25677697.s6.e0" e2="DDI-PubMed.25677697.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25677697.s6.e0" e2="DDI-PubMed.25677697.s6.e1" /></sentence><sentence text="" /><sentence text="High-throughput screening and multimodality imaging approach of SBL and 3D-US in a xenograft NOG mouse model of TCL were used to explore the in vitro and in vivo activity of pralatrexate and romidepsin in combination"><entity charOffset="174-186" id="DDI-PubMed.25677697.s8.e0" text="pralatrexate" /><entity charOffset="191-201" id="DDI-PubMed.25677697.s8.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.25677697.s8.e0" e2="DDI-PubMed.25677697.s8.e0" /><pair ddi="false" e1="DDI-PubMed.25677697.s8.e0" e2="DDI-PubMed.25677697.s8.e1" /></sentence><sentence text=" Corresponding mass spectrometry-based pharmacokinetic and immunohistochemistry-based pharmacodynamic analyses of xenograft tumors were performed to better understand a mechanistic basis for the drug:drug interaction" /><sentence text="" /><sentence text="In vitro, pralatrexate and romidepsin exhibited concentration-dependent synergism in combination against a panel of TCL cell lines"><entity charOffset="10-22" id="DDI-PubMed.25677697.s11.e0" text="pralatrexate" /><entity charOffset="27-37" id="DDI-PubMed.25677697.s11.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.25677697.s11.e0" e2="DDI-PubMed.25677697.s11.e0" /><pair ddi="false" e1="DDI-PubMed.25677697.s11.e0" e2="DDI-PubMed.25677697.s11.e1" /></sentence><sentence text=" In a NOG murine model of TCL, the combination of pralatrexate and romidepsin exhibited enhanced efficacy compared with either drug alone across a spectrum of tumors using complementary imaging modalities, such as SBL and 3D-US"><entity charOffset="50-62" id="DDI-PubMed.25677697.s12.e0" text="pralatrexate" /><entity charOffset="67-77" id="DDI-PubMed.25677697.s12.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.25677697.s12.e0" e2="DDI-PubMed.25677697.s12.e0" /><pair ddi="false" e1="DDI-PubMed.25677697.s12.e0" e2="DDI-PubMed.25677697.s12.e1" /></sentence><sentence text="" /><sentence text="Collectively, these data strongly suggest that the combination of pralatrexate and romidepsin merits clinical study in patients with TCLs"><entity charOffset="66-78" id="DDI-PubMed.25677697.s14.e0" text="pralatrexate" /><entity charOffset="83-93" id="DDI-PubMed.25677697.s14.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.25677697.s14.e0" e2="DDI-PubMed.25677697.s14.e0" /><pair ddi="false" e1="DDI-PubMed.25677697.s14.e0" e2="DDI-PubMed.25677697.s14.e1" /></sentence><sentence text="" /></document>